Kidney allografts undergo pretransplant cold ischemia and consequent ischemia-reperfusion injury (IR). Poly (ADP-Ribose) polymerase (PARP-1) overactivation leads to massive NADϩ consumption and ATP depletion with induction of cellular necrosis under ischemic conditions, which may lead to an increase in acute tubular necrosis (ATN) and a delay in total recovery of renal function (RFR) of the transplanted organ. Materials and Methods. Nuclear PARP-1 immunohistochemical expression (clone: PARP01) was studied in 155 paraffin-embedded renal biopsies from suboptimal donors and 95 kidney allograft biopsies with histopathological diagnosis of ATN.
A CUTE FAILURE of the transplanted kidney is a major problem in the early posttransplant phase and is acknowledged as a cause of allograft loss. Early renal transplant dysfunction is mainly due to ischemic damage (acute tubular necrosis [ATN] ), rejection, infection, and cyclosporine toxicity. 1 Renal ischemia is a major cause of acute renal failure, whether or not caused during transplantation, initiating a complex and interrelated sequence of events that result in the injury and eventual death of renal cells.
2, 3 Salahudeen et al recently studied 6465 kidney transplant patients using UNOS data and concluded that prolonged cold ischemia is a strong risk factor for delayed graft function and is also a significant predictor of long-term graft loss, 4 as previously reported. 5, 6 The prognosis is complicated because reperfusion, although essential for the survival of ischemic renal tissue, causes additional damage (reperfusion injury) 7, 8 that contributes to the renal dysfunction and injury associated with ischemia-reperfusion (I/ R).
2, 8 Within the kidney, the proximal tubule appears to be particularly susceptible to I/R injury, leading to ATN, which plays a pivotal role in the pathogenesis of early transplanted kidney dysfunction. 1, 3, 8 Poly(ADP-ribose)polymerase (PARP-1) is a nuclear zinc-finger DNA-binding protein with a molecular weight of 113 kDa that specifically detects DNA-strand breaks or nicks produced by different genotoxic agents in mammalian cells. 9 PARP-1 catalyzes the ADP ribosylation of proteins using NAD(ϩ) as the substrate. 10 The activation of PARP is a consequence of ischemic injury and results in a depletion of intracellular NAD(ϩ), 11 16 ). Our group previously demonstrated PARP-1 expression in the tubules of kidneys from aging donors and its significant statistical relationship with parameters of functional reserve (serum creatinine and time required to achieve effective diuresis). 17 Mangino et al 18 recently demonstrated in an experimental canine model that: (1) renal cortical PARP enzyme activity increases with cold-storage time after the tissues are reperfused; (2) cold storage without reperfusion does not increase PARP activity; (3) the cold storage/reperfusioninduced increase in PARP activity is abrogated when the tissues undergo prior warm ischemia; and (4) PARP activity in cold-stored renal tissue may be dependent on the degree of preservation stress because PARP increased after reperfusion after 24 hours of cold storage only in kidneys flushed with Lactate Ringer solution compared with University of Wisconsin-flushed kidneys.
The present study provides statistical evidence in support of the hypothesis that increased tubular expression of PARP-1 in human allograft kidneys that are suboptimal or develop posttransplant ATN contributes to a subsequent delayed renal function.
MATERIALS AND METHODS
One hundred fifty-five human kidney wedge biopsies from suboptimal donors at our hospital were fixed in Glyofix (Pacisa-Giralt, Barcelona, Spain) and paraffin-embedded by a microwave-accelerated procedure to determine pretransplant glomerular, vascular, and tubulointerstitial lesions according to Andalusian protocol 19 ; 95 kidney cylinder biopsies from transplant patients at Hermanos Almeijeiras Hospital in La Havana were fixed in 10% buffered formalin and paraffin-embedded by standard procedure to determine the degree of acute tubular necrosis. The nuclear expression of PARP-1 was characterized by incubating sections for 60 minutes at room temperature with PARP-1 monoclonal antibody (clone PAR01) (LabVision Fremont, Calif, USA). The immunohistochemistry study was done on an automatic immunostainer (LabVision) using the streptavin-biotin-peroxidase-based method followed by development with diaminobenzidine (Master Diagnóstica, Granada, Spain). The positivity and intensity of the immunostaining was calculated semiquantitatively using a 0 to 3 scale (0, absence; 1 [1% to 9% of tubular nuclei positives]; 2 [10% to 49%]; 3 [Ͼ50%]).
Data were gathered on renal function parameters (serum creatinine, creatinine clearance [mL/min per 1.73m 2 ] at different times), donor and recipient age and sex, cold-ischemia, reanastomosis times, effective diuresis, immunosuppression regimens, morphological score, and number of hemodialysis sessions.
Statistical Analysis
The Kolmogorov-Smirnov test was used to test the normality of the variables. After the descriptive analysis, the Spearman correlation and Mann-Whitney U test were performed to determine statistical significances. To test the relationship among variables, bivariate analysis was performed followed by multivariate analysis to establish the statistical model; the confidence interval was 95% (P Ͻ 0.05). The statistical analysis was performed using the SPSSWindows 12.0 program (SPSS Inc, Chicago, Ill, USA). Table 1 lists the mean values of the two series of renal biopsies studied. The frequency distribution of PARP-1 immunohistochemical expression in the renal biopsies from suboptimal donors was: zero, 41.0%; one, 27.9%; two, 18.0%; and three, 13.1%; and the inverse of the distribution observed in the renal biopsies with ATN, which was: zero, 1.1%; one, 12.6%; two, 31.6%; and three, 54.7%. We detected a statistically significant difference in PARP-1 expression between biopsies with ATN and those from suboptimal donors (2.40 Ϯ 0.74 vs 0.92 Ϯ 1.13, P ϭ 0.0001 Mann-Whitney).
RESULTS
PARP-1 expression showed a statistically significant relationship with the duration of cold ischemia (Rho coefficient ϭ 0.803, P ϭ 0.0001, Spearman test), time to effective diuresis (Rho coefficient ϭ 0.779, P ϭ 0.0001, Spearman test), and serum creatinine levels at three months (Rho coefficient ϭ 0.649, P ϭ 0.0001, Spearman test). Kidneys from ATN patients who failed to reduce serum creatinine levels to below 1.7 mg/dL after transplantation showed a different intensity of PARP-1 expression from those who succeeded (creatinine Ͻ1.7, PARP 1.71 Ϯ 0.58 vs creatinine Ͼ1.7, PARP 2.73 Ϯ 0.57, P Ͻ 0.0001, Mann-Whitney U test). Multivariate analysis was used to establish a predictive model of short-term renal function according to tubular expression levels of PARP-1, time of cold ischemia, and delay in total recovery of renal function in patients with kidneys from suboptimal donors or kidneys with ATN (R ϭ 0.599, P ϭ 0.06; R ϭ 0.667 P ϭ 0.001 [ANOVA]; respectively).
DISCUSSION
A prolonged cold ischemia time is a strong risk factor for delayed graft function, graft loss 4,10 and long-term changes after kidney transplantation. 18 The present study revealed a variable intensity of immunohistochemical expression of PARP-1 in tubular cells of kidneys from suboptimal donors and demonstrated that a lesser tubular expression of PARP-1 was related to an earlier recovery of renal function. Likewise, this research revealed a high intensity of PARP-1 immunohistochemical expression in the tubular cells of human transplant kidneys with ATN compared with those from suboptimal donors and demonstrated a relationship between a higher tubular expression of PARP-1 and a delayed renal function. In addition, transplanted kidneys in patients with serum creatinine levels that did not reduce to below 1.7 mg/dL presented almost double the intensity of PARP-1 expression. These findings indicate that the degree of PARP-1 activation may be related to the extent of human renal tubular injury and to the renal function.
Activation of the PARP-1 pathway, a recently discovered cell injury mechanism, 20,21 is currently regarded as the final common effector in the pathogenesis of various types of tissue injury, including systemic inflammation, circulatory shock, and I/R. A major contributor to the development and progression of I/R-induced renal failure is the loss of functioning tubular epithelial cells via cell deletion or cell death processes (necrosis or apoptosis). Donor kidneys inevitably undergo a period of ischemia. In our series, the periods of cold ischemia were significantly longer for the kidneys in patients with ATN than in those from suboptimal donors ( Table 1 ). The variable resistance to ischemia of the heterogeneous renal cell population is well known. The proximal straight tubule and to some extent the thick ascending limb of the loop of Henle are more sensitive to ischemia. It can be hypothesized that these cells tend to suffer more necrosis in comparison with less sensitive cells, [22] [23] [24] and that PARP-1 activation may be one of the pathogenic mechanisms. Thus, in our 94 patients with ATN, the kidneys that tolerated a long period of cold ischemia had the highest levels of PARP-1 (cold ischemia Ͻ24 hours, PARP-1 ϭ 1.71 Ϯ 0.62 vs cold ischemia Ն24 hours, PARP-1 ϭ 2.86 Ϯ 0.350). In fact, the lowest PARP-1 expression (1%-9% of tubular nuclei positive) was only observed in kidneys with less than 24 hours of cold ischemia (mean, 16.36 hours range, 12 to 20 hours). 25 Delayed renal function after kidney transplantation may be due to various factors, such as the condition of the transplanted kidney and the compliance of the vascular system in the renal graft or recipient. The functional capacity of renal tubular cells contributes significantly to adequate renal function. Hence, measures taken to ameliorate the condition of these cells may also improve the outcome of kidney transplantation. 26 We found a statistically significant relationship between a higher expression of PARP-1 and delayed renal function, observing a moderate or intense PARP-1 expression (mean 2.64 Ϯ 0.68) in all kidneys suffering Ͼ10 hours of cold ischemia and a mild expression (1.26 Ϯ 0.86) in those with cold ischemia of Յ10 hours.
In conclusion, multivariate analysis demonstrated that PARP-1 expression and duration of cold ischemia in kidney biopsies with ATN predicted the short-term delay in total recovery of renal function and serum creatinine in the first month.
